Fauci: Safe and effective vaccine is coming by November

Ross J Burland FXStreet

While COVID-19 has infected more than 25 million people worldwide as of today, Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases may have just given markets a positive to start the week off on the front foot.

Fauci has said that a vaccine could be here as soon as November.

Key comments

"The way the pace of the enrolment is going on and the level of the infections that are going on in the United States, it is likely that we’ll get an answer by the end of the year.

"It is conceivable that we would get an answer before that.

"I would say a safe bet is at least knowing that you have a safe and effective vaccine by November, December,” he told the Times newspaper in the U.K. He declined to comment on what vaccine could be a front-runner, but added, “I would not be satisfied until a vaccine was proven to be safe and effective before it was actually approved for general use."

Market implications

The US stock market closed last week on a strong standing which should buoy the Asian session at the start of the week.

Additional hopes for a vaccine is positive as well which could the catalyst for a bid back into USD/JPY.

The Chart of the Week: Bears looking for shorts for favourable risk/reward territory

More on the US stock market here: S&P 500 Weekly Forecast: Best August since 1986, how will September start?

Author

Ross J Burland

FXStreet

Ross J Burland, born in England, UK, is a sportsman at heart. He played Rugby and Judo for his county, Kent and the South East of England Rugby team.

Markets move fast. We move first.

Orange Juice Newsletter brings you expert driven insights - not headlines. Every day on your inbox.

Editor's Picks

EUR/USD moves sideways below 1.1800 on Christmas Eve

EUR/USD struggles to find direction and trades in a narrow channel below 1.1800 after posting gains for two consecutive days. Bond and stock markets in the US will open at the usual time and close early on Christmas Eve, allowing the trading action to remain subdued.

GBP/USD keeps range around 1.3500 amid quiet markets

GBP/USD keeps its range trade intact at around 1.3500 on Wednesday. The Pound Sterling holds the upper hand over the US Dollar amid pre-Christmas light trading as traders move to the sidelines heading into the holiday season.

Gold retreats from record highs, trades below $4,500

Gold retreats after setting a new record-high above $4,520 earlier in the day and trades in a tight range below $4,500 as trading volumes thin out ahead of the Christmas break. The US Dollar selling bias remains unabated on the back of dovish Fed expectations, which continues to act as a tailwind for the bullion amid persistent geopolitical risks.

Bitcoin slips below $87,000 as ETF outflows intensify, whale participation declines

Bitcoin price continues to trade around $86,770 on Wednesday, after failing to break above the $90,000 resistance. US-listed spot ETFs record an outflow of $188.64 million on Tuesday, marking the fourth consecutive day of withdrawals.

Economic outlook 2026-2027 in advanced countries: Solidity test

After a year marked by global economic resilience and ending on a note of optimism, 2026 looks promising and could be a year of solid economic performance. In our baseline scenario, we expect most of the supportive factors at work in 2025 to continue to play a role in 2026.

Avalanche struggles near $12 as Grayscale files updated form for ETF

Avalanche trades close to $12 by press time on Wednesday, extending the nearly 2% drop from the previous day. Grayscale filed an updated form to convert its Avalanche-focused Trust into an ETF with the US Securities and Exchange Commission.